Q08499 (PDE4D_HUMAN) Homo sapiens (Human)

3',5'-cyclic-AMP phosphodiesterase 4D UniProtKBInterProSTRINGInteractive Modelling

809 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12); 1 identical sequence: Homo sapiens: A0A140VJR0

Available Structures

109 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
crystal structure of PDE4D catalytic domain and zardaverine complex
1mkd
homo-6-mer388-715
6×ZN; 6×MG; 6×ZAR;
Assess
PDE4 complexed with inhibitor
4wcu
homo-4-mer387-738
4×3KQ; 4×ZN; 4×MG;
Assess
Crystal structure of PDE4D2 in complex with inhibitor LEO39652
6zba
homo-4-mer381-714
4×QDT; 28×EDO; 4×DMS; 4×MG; 4×ZN;
Assess
Crystal structure of PDE4D2 in complex with (R,S)-rolipram
1oyn
homo-4-mer381-714
8×ZN; 4×ROL;
Assess
Crystal structure of PDE4D in complex with L-869298
2fm0
homo-4-mer381-714
4×ZN; 4×MG; 4×M98;
Assess
Crystal structure of PDE4D2 in complex with inhibitor L-869299
2fm5
homo-4-mer381-714
4×ZN; 4×MG; 4×M99;
Assess
Structure of PDE4D2-IBMX
1zkn
homo-4-mer381-714
4×ZN; 4×MG; 4×IBM;
Assess
The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysis
1ptw
homo-4-mer381-714
8×ZN; 4×AMP;
Assess
Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor select…
1q9m
homo-4-mer381-714
8×ZN; 4×ROL;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-42a
7b9h
homo-2-mer382-714
2×ZN; 8×MG; 28×EDO; 2×T3K;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-41b
7ay6
homo-2-mer382-714
2×S8Q; 2×ZN; 8×MG; 14×EDO;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-18a
6f8w
homo-2-mer383-714
2×ZN; 5×MG; 2×D0E;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-32a
6fdc
homo-2-mer385-714
2×ZN; 5×MG; 2×EDO; 1×DD5; 1×D5N;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-4a
6f8t
homo-2-mer386-714
2×ZN; 5×MG; 2×CZT;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-7b
6f6u
homo-2-mer386-714
3×MG; 2×ZN; 2×CV8; 2×GOL;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-18b
6f8v
homo-2-mer387-714
2×ZN; 4×MG; 2×D0B;
Assess
Crystal structure of PDE4D catalytic domain in complex with arctigenin
6lrm
homo-2-mer388-714
2×ZN; 2×MG; 2×EQC; 26×EDO;
Assess
Structure of the PDE4D-cAMP complex
2pw3
homo-2-mer388-714
2×ZN; 2×CMP;
Assess
Crystal structure of PDE4D2 in complex with inhibitor NPV
2qyn
homo-2-mer388-714
2×NPV; 2×ZN; 2×MG;
Assess
Crystal structure of PDE4D catalytic domain in complex with Apremilast
7cbq
homo-2-mer388-714
3×MG; 2×ZN; 11×EDO; 2×A9L;
Assess
The structure of the catalytic domain of human PDE4d with 4-(3-Butoxy-4-methoxyphenyl)methyl-2-imid…
3k4s
homo-2-mer388-714
2×ZN; 2×0MO; 2×MG;
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 21d
7xaa
homo-2-mer388-714
2×ZN; 2×MG; 2×AQL;
Assess
Crystal structure of PDE4D catalytic domain in complex with compound 36
7cbj
homo-2-mer388-713
2×ZN; 2×MG; 2×FTX; 12×EDO;
Assess
Crystal structure of PDE4D complexed with benzbromarone
8k4h
homo-2-mer388-713
2×ZN; 2×MG; 2×R75; 2×EDO;
Assess
Crystal structure of PDE4D complexed with ethaverine hydrochloride
8k4c
homo-2-mer388-713
2×VIC; 2×MG; 2×ZN; 1×EDO;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6imi
homo-2-mer389-713
3×MG; 2×ZN; 2×AH6; 11×EDO;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6imd
homo-2-mer389-713
2×ZN; 4×MG; 2×AH9; 11×EDO;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6imr
homo-2-mer389-713
2×ZN; 2×MG; 2×AJX; 14×EDO;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6im6
homo-2-mer389-713
2×ZN; 4×MG; 2×AH3; 13×EDO;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6ind
homo-2-mer389-713
2×AKO; 3×MG; 2×ZN; 5×EDO;
Assess
PDE4D complexed with inhibitor
4w1o
homo-2-mer389-713
2×3GJ; 4×ZN;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6imt
homo-2-mer390-713
2×ZN; 2×MG; 10×EDO; 2×AK0;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6imb
homo-2-mer390-713
2×ZN; 4×MG; 2×AH9; 15×EDO;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6imo
homo-2-mer390-713
2×ZN; 3×MG; 2×AJL; 12×EDO;
Assess
Crystal structure of PDE4D complexed with CX-4945
8w4q
homo-2-mer390-713
2×MG; 2×ZN; 2×3NG; 6×EDO;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6ink
homo-2-mer390-713
2×ZN; 2×MG; 2×AKU; 4×EDO;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-26g
6f8x
homo-2-mer392-715
2×ZN; 4×MG; 2×D08; 2×EDO; 1×DMS;
Assess
PDE4D crystal structure in complex with small molecule inhibitor
5k32
homo-2-mer390-713
2×ZN; 2×MG; 2×6Q2; 32×EDO;
Assess
Crystal structure of PDE4D complexed with a novel inhibitor
6inm
homo-2-mer390-713
2×ZN; 2×MG; 2×AKU; 1×EDO;
Assess
Crystal structure of human phosphodiesterase 4d (PDE4d) with papaverine.
3iak
homo-2-mer388-711
2×ZN; 2×MG; 2×EV1;
Assess
Crystal structure of PDE4D complexed with CVT-313
8w4r
homo-2-mer390-712
2×AJR; 2×MG; 2×ZN; 8×EDO;
Assess
Crystal structure of PDE4D complexed with glycyrrhisoflavone
7yqf
homo-2-mer390-712
2×ZN; 2×MG; 2×JN0; 5×EDO;
Assess
Crystal structure of PDE4D complexed with licoisoflavone A
7ysx
homo-2-mer390-712
2×ZN; 2×MG; 2×JU3; 5×EDO;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-54
6f8r
homo-2-mer392-714
2×CZK; 4×MG; 2×ZN; 1×EDO;
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 22d
7xab
homo-2-mer390-712
2×ZN; 2×MG; 2×AWI;
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-20b
6f8u
homo-2-mer392-714
2×ZN; 5×MG; 3×CZQ;
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 23a
7xbb
homo-2-mer390-712
2×ZN; 2×MG; 2×B6V;
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-48
6njh
monomer326-718
1×ZN; 2×MG; 1×KRD;
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN14770
6njj
monomer326-718
2×ZN; 1×MG; 1×KR7; 1×BTB; 1×SO4; 1×EDO;
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-49
6nji
monomer326-718
1×ZN; 1×MG; 1×KR4;
Assess
Crystal structure of human phosphodiesterase 4D with bound allosteric modulator
3iad
monomer326-714
1×15X; 1×ZN; 1×MG; 1×EPE;
Assess
Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871
3g4g
monomer327-714
1×ZN; 1×MG; 1×CA; 1×D71;
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004
6boj
monomer390-734
2×ZN; 1×MG; 1×E31; 1×CL;
Assess
Crystal structure of human phosphodiesterase 4d with d155988/pmnpq
3g58
monomer380-714
1×ZN; 1×MG; 1×SO4; 1×988; 4×EDO;
Assess
Crystal structure of PDE4D catalytic domain complexed with Selaginpulvilins K
5wqa
monomer381-714
1×J20; 1×ZN; 1×MG;
Assess
Crystal structure of human phosphodiesterase 4d with d155871
3g4i
monomer384-714
1×ZN; 1×MG; 1×SO4; 1×D71; 3×EOH;
Assess
Crystal structure of the catalytic domain of PDE4D2 with (S)-N-(3-{1-[1-(3-Cyclopropylmethoxy-4-dif…
3v9b
monomer384-714
1×IHM; 2×ZN;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-048
6ftw
monomer383-713
1×ZN; 1×MG; 13×EDO; 1×EPE; 1×E6Z;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-617
7aag
monomer384-713
1×ZN; 2×MG; 1×QWT; 15×EDO; 1×PEG; 5×DMS; 1×EPE;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-769
7abe
monomer384-713
1×ZN; 1×MG; 19×EDO; 1×J2E; 1×EPE;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-226
6fdi
monomer384-713
1×ZN; 1×MG; 21×EDO; 1×PEG; 1×D5T;
Assess
Crystal structure of human phosphodiesterase 4d with rolipram
3g4k
monomer384-713
1×ZN; 1×MG; 1×SO4; 1×ROL; 8×EDO;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356
6fe7
monomer384-713
1×ZN; 1×MG; 15×EDO; 6×PEG; 1×D62; 1×EPE;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-656
7ab9
monomer384-713
1×ZN; 1×MG; 10×EDO; 1×QWZ;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-001
5lbo
monomer384-713
1×ZN; 1×MG; 8×EDO; 2×DTT; 1×6M5;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-768
7abd
monomer384-713
1×ZN; 1×MG; 7×EDO; 1×EPE; 1×RLW;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-007
6fw3
monomer385-713
1×ZN; 1×MG; 20×EDO; 1×PEG; 1×EPE; 1×E8H;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1439
6fet
monomer385-713
1×ZN; 1×MG; 19×EDO; 1×PEG; 1×D68; 1×EPE; 1×NI;
Assess
Crystal structure of the catalytic domain of PDE4D2 with compound 10D
3sl4
monomer385-713
2×ZN; 16×EDO; 2×DMS; 1×PEG; 1×PO4; 1×JN4;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-637
6iag
monomer385-713
1×ZN; 1×MG; 10×EDO; 1×E3Q;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-053
6rcw
monomer385-713
1×ZN; 1×MG; 12×EDO; 1×PEG; 1×DTT;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-425
6ft0
monomer385-713
1×ZN; 1×MG; 9×EDO; 1×E6E; 1×EPE;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1361
7abj
monomer385-713
1×ZN; 1×MG; 13×EDO; 1×DMS; 1×863; 1×EPE;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH A TETRAFLUORANLINE COMPOUND
5tkb
monomer386-714
1×ZN; 1×MG; 1×SO4; 3×EOH; 1×7DJ;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-635
7a9v
monomer385-713
1×ZN; 1×MG; 9×EDO; 1×EPE;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-654
7a8q
monomer385-713
1×ZN; 1×MG; 9×EDO; 1×EPE;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-417
6ibf
monomer385-713
1×ZN; 1×MG; 9×EDO; 1×EPE; 1×4I7;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-3098
6fta
monomer385-713
1×ZN; 1×MG; 7×EDO; 1×E6N; 1×EPE;
Assess
Crystal structure of human phosphodiesterase 4d with roflumilast
3g4l
monomer385-713
1×ZN; 1×MG; 1×SO4; 1×ROF; 3×EDO;
Assess
Crystal structure of the catalytic domain of PDE4D2 with compound 2
4ogb
monomer385-712
1×2SR; 8×EDO; 1×PEG; 2×ZN; 2×DMS;
Assess
Crystal structure of the catalytic domain of PDE4D2 complexed with compound 10d
3sl5
monomer385-712
2×ZN; 1×J25; 2×EDO; 1×DMS;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1335
6hwo
monomer385-711
15×EDO; 2×PEG; 1×ZN; 1×FFZ; 1×MG; 1×EPE;
Assess
Crystal structure of the apo form of the catalytic domain of PDE4D2
3sl3
monomer385-711
17×EDO; 1×PEG; 2×ZN; 1×PO4;
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 1
6kjz
monomer387-713
1×ZN; 1×MG; 1×MKU;
Assess
Crystal structure of the catalytic domain of PDE4D2 with compound 12c
3sl6
monomer386-712
2×ZN; 9×EDO; 1×JN8;
Assess
Crystal structure of the catalytic domain of PDE4D2 with compound 10o
3sl8
monomer386-712
13×EDO; 2×ZN; 1×PEG; 1×JN7;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p…
1y2k
monomer388-713
1×ZN; 1×MG; 1×7DE; 18×EDO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1H-pyrazole-4-carboxyli…
1y2b
monomer388-713
1×ZN; 1×MG; 1×DEE; 11×EDO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Cilomilast
1xom
monomer388-713
1×ZN; 1×MG; 1×CIO; 9×EDO;
Assess
Crystal structure of PDE4D2 in complex with inhibitor (S_Zl-n-91)
5wh6
monomer388-713
1×AKJ; 1×ZN; 2×MG;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-phenyl-1H-pyrazole-4-…
1y2c
monomer388-713
1×ZN; 1×MG; 1×3DE; 10×EDO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-methoxy-phenyl)-3,5-dimethyl-1H…
1y2d
monomer388-713
1×ZN; 1×MG; 1×4DE; 12×EDO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Piclamilast
1xon
monomer388-713
1×ZN; 1×MG; 1×PIL; 1×B3P; 20×EDO;
Assess
Crystal structure of the PDE4D2 catalytic domain in complex with inhibitor (R)-Zl-n-91
5wh5
monomer388-713
1×R91; 1×ZN; 2×MG;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Roflumilast
1xoq
monomer388-713
1×ZN; 1×MG; 12×EDO; 1×ROF;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-amino-phenyl)-3,5-dimethyl-1H-p…
1y2e
monomer388-713
1×ZN; 1×MG; 1×5DE; 8×EDO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With AMP
1tb7
monomer389-713
1×ZN; 1×MG; 1×AMP; 14×EDO; 1×B3P;
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1086
6feb
monomer390-714
11×EDO; 2×D5Z; 1×MG; 1×ZN; 1×EPE;
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 18d
7f2m
monomer388-712
1×ZN; 1×MG; 1×1GF;
Assess
Crystal structure of the PDE4D catalytic domain in complex with osthole
6akr
monomer390-714
2×ZN; 1×A0O;
Assess
PDE4 crystal structure in complex with small molecule inhibitor
5k1i
monomer389-713
1×6PT; 1×ZN; 1×MG;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Zardaverine
1xor
monomer390-713
1×ZN; 1×MG; 1×ZAR;
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Rolipram
1tbb
monomer390-713
1×ZN; 1×MG; 1×ROL; 5×EDO;
Assess
Crystal structure of PDE4D catalytic domain complexed with 33a
7w4y
monomer390-713
1×ZN; 1×MG; 1×8GO;
Assess
Crystal structure of PDE4D catalytic domain complexed with 17
7w4x
monomer390-713
1×ZN; 1×MG; 1×8G7;
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 4e
6kk0
monomer390-712
1×M36; 1×ZN; 1×MG;
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 17a
7f2k
monomer390-711
1×ZN; 1×MG; 1×0X8;
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 18a
7f2l
monomer393-712
1×ZN; 1×MG; 1×1AS;
Assess
The structure of the RACK1 interaction sites located within the unique N-terminal region of the cAM…
1e9k
monomer250-280
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4wzi.1.Ahomo-2-mer0.76223-713
2×ZN;79.22
Assess

13 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24wzi.1.Ahomo-2-mer0.7687-577
2×ZN;79.22
Assess
Isoform 34wzi.1.Ahomo-2-mer0.7618-508
2×ZN;78.76
Assess
Isoform 44wzi.1.Ahomo-2-mer0.7845-488
2×ZN;80.68
Assess
Isoform 54wzi.1.Ahomo-2-mer0.801-411
2×ZN;82.51
Assess
Isoform 64wzi.1.Ahomo-2-mer0.76159-649
2×ZN;79.22
Assess
Isoform 61e9k.1.Amonomer0.6012-49
100.00
Assess
Isoform 71e9k.1.Amonomer0.6512-49
100.00
Assess
Isoform 84wzi.1.Ahomo-2-mer0.8016-422
2×ZN;80.43
Assess
Isoform 94wzi.1.Ahomo-2-mer0.76101-591
2×ZN;80.67
Assess
Isoform 94rxo.2.Ahomo-2-mer0.50305-393
22.37
Assess
Isoform 104wzi.1.Ahomo-2-mer0.7693-583
2×ZN;79.22
Assess
Isoform 114wzi.1.Ahomo-2-mer0.75162-652
2×ZN;79.22
Assess
Isoform 121e9k.1.Amonomer0.6412-49
100.00
Assess